Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of St...( - Stockholders to Vote on Merger Agre...),Health

- Stockholders to Vote on Merger Agreement with Pfizer -

MADISON, N.J., June 18 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) today announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission for its Annual Meeting of Stockholders. Among other matters, stockholders will vote on Wyeth's merger agreement with Pfizer (NYSE: PFE), which was announced on January 26, 2009.

Wyeth's Annual Meeting of Stockholders will be held on Monday, July 20, 2009 at 9:00 a.m. EDT. The meeting will be held at the Hyatt Morristown (Morristown, N.J.). On that day, a live webcast of the meeting will be available to all interested parties. The meeting may be accessed by visiting the Wyeth website at www.wyeth.com and clicking on the "Investor Relations" icon.

Stockholders of record as of the close of business on June 5, 2009 will be entitled to vote at the meeting. Under the terms of the merger agreement, each outstanding share of Wyeth common stock would be converted into the right to receive $33 in cash and 0.985 of a share of Pfizer common stock after closing.

The Wyeth Board of Directors has approved the merger agreement and recommends that stockholders vote "FOR" the approval of the merger agreement. Completion of the transaction is subject to certain conditions, including approval by the stockholders of Wyeth and other customary closing conditions. Subject to the satisfaction of these closing conditions, the transaction is expected to be completed at the end of the third quarter or during the fourth quarter of 2009.

Wyeth is one of the world's largest research-driven pharmaceutical and health
'/>"/>